| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | President And CEO
3 companies
Southwell David P is a Chief Executive Officer at TCRX with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 2 sells.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2017 | RCKT Rocket Pharmaceuticals, Inc. | President And CEO | Buy | 60,000 | $1.75 | $105,000.00 | +2,170% | |
| Jul 6, 2015 | PTCT Ptc Therapeutics, Inc. | Director | Sale+OE | 23,604 | $47.52 | $1,121,694.00 | -97.1% |